Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 11478510
Chimeric antigen receptor and methods of use thereof
granted -
US 11479794
Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
granted -
US 11478425
Extended release compositions comprising pyridostigmine
granted -
US 11479775
RNA targeting of mutations via suppressor tRNAs and deaminases
granted -
US 11479769
Technique for treating cancer using structurally-reinforced S-TuD
granted -
US 11479774
Methods of treating cancer harboring hemizygous loss of TP53
granted -
US 11479771
Antisense oligonucleotides for the treatment of eye disease
granted -
US 11479614
Methods for treating cancer or modulating T cells or NK cells in a subject with cancer by administering cells comprising chimeric cytokine receptors
granted -
US 11479772
Thiomorpholino oligonucleotides for the treatment of muscular dystrophy
granted -
US 11479617
Chelator-functionalized glycosaminoglycans
granted -
US 11479595
Methods for modulating an immune response
granted -
US 11479602
Methods of treating C5-associated diseases comprising administering anti-C5 antibodies
granted -
US 11479543
Heterocyclic RIP1 kinase inhibitors
granted -
US 11479579
Therapeutic compounds and methods
granted -
US 11479611
HLA-G specific chimeric antigen receptor, nucleic acid, HLA-G specific chimeric antigen receptor expression plasmid, HLA-G specific chimeric antigen receptor expressing cell, use thereof, and pharmaceutical composition for treating cancer
granted -
US 11479613
Methods for treating cancer or modulating T cells or NK cells in a subject by administering cells comprising chimeric transmembrane proteins
granted -
US 11479576
Nucleic acid prodrugs
granted -
US 11479556
Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway
granted -
US 11478511
Lymphocyte biomarkers for determining the clinical response to cell therapy
granted -
US 11479560
OX2R compounds
granted -
US 11479545
Compositions and methods for inhibiting phenyl triazole MLL1-WDR5 protein-protein interaction
granted -
FR 3121841
Traitement des hyperammoniémies
granted -
US 11471442
Administration of gut-selective JAK3 inhibitor
granted -
US 11472808
Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.